Revolo Biotherapeutics Enters into Partnership Agreement with Northway Biotech to Manufacture its Novel Binding Immunoglobulin Protein, ‘1805, to Support Phase 2 Trials in Rheumatoid Arthritis and Uveitis
June 09, 2021 08:30 ET
|
Revolo Biotherapeutics
NEW ORLEANS and LONDON and WALTHAM, Mass. and VILNIUS, Lithuania, June 09, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing therapies that...
Revolo Biotherapeutics to Present at 3rd Annual Treg Directed Therapies Summit
May 14, 2021 08:00 ET
|
Revolo Biotherapeutics
NEW ORLEANS and LONDON, May 14, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing therapies that reset the immune system to achieve superior...
Revolo Biotherapeutics Announces Positive Data from Additional Phase 1 Clinical Trial of ‘1104, its Peptide Drug for Allergic Disease
May 04, 2021 08:30 ET
|
Revolo Biotherapeutics
NEW ORLEANS and LONDON, May 04, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing therapies that reset the immune system to achieve superior...
Revolo Biotherapeutics Enters Manufacturing Agreement with CordenPharma to Scale Up and Manufacture ‘1104 for the Treatment of Eosinophilic Esophagitis and Allergic Disease
April 15, 2021 08:00 ET
|
Revolo Biotherapeutics
NEW ORLEANS and LONDON, April 15, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a Company developing therapies that reset the immune system to achieve superior...
Immune Regulation Announces Rebranding to Revolo Biotherapeutics, Reflecting a Revolutionary Approach to Resetting the Immune System to Treat Autoimmune and Allergic Diseases
March 05, 2021 08:30 ET
|
Revolo Biotherapeutics
-- Plans to initiate four Phase 2 trials in second half of 2021-- -- Exploring additional autoimmune and allergic disease indications for portfolio candidates -- NEW ORLEANS and LONDON, March ...
Immune Regulation to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
January 08, 2021 08:00 ET
|
Immune Regulation
LONDON AND NEW ORLEANS, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Immune Regulation, LTD, announced today that the company will give a corporate overview at the virtual 39th Annual J.P. Morgan Healthcare...